These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3593690)

  • 1. Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy.
    Goormaghtigh E; Brasseur R; Huart P; Ruysschaert JM
    Biochemistry; 1987 Mar; 26(6):1789-94. PubMed ID: 3593690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites.
    Henry N; Fantine EO; Bolard J; Garnier-Suillerot A
    Biochemistry; 1985 Dec; 24(25):7085-92. PubMed ID: 4084563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adriamycin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes.
    Nicolay K; van der Neut R; Fok JJ; de Kruijff B
    Biochim Biophys Acta; 1985 Sep; 819(1):55-65. PubMed ID: 4041451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.
    Goormaghtigh E; Huart P; Praet M; Brasseur R; Ruysschaert JM
    Biophys Chem; 1990 Apr; 35(2-3):247-57. PubMed ID: 2204444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin inhibits the formation of non-bilayer lipid structures in cardiolipin-containing model membranes.
    Goormaghtigh E; Vandenbranden M; Ruysschaert JM; De Kruijff B
    Biochim Biophys Acta; 1982 Feb; 685(2):137-43. PubMed ID: 6277379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a specific complex between adriamycin and negatively-charged phospholipids.
    Goormaghtigh E; Chatelain P; Caspers J; Ruysschaert JM
    Biochim Biophys Acta; 1980 Mar; 597(1):1-14. PubMed ID: 7370238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives.
    Goormaghtigh E; Huart P; Brasseur R; Ruysschaert JM
    Biochim Biophys Acta; 1986 Sep; 861(1):83-94. PubMed ID: 3019400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study.
    Karczmar GS; Tritton TR
    Biochim Biophys Acta; 1979 Nov; 557(2):306-19. PubMed ID: 583025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes.
    Nicolay K; Timmers RJ; Spoelstra E; Van der Neut R; Fok JJ; Huigen YM; Verkleij AJ; De Kruijff B
    Biochim Biophys Acta; 1984 Dec; 778(2):359-71. PubMed ID: 6498197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin as a probe for the transversal distribution of cardiolipin in the inner mitochondrial membrane.
    Cheneval D; Müller M; Toni R; Ruetz S; Carafoli E
    J Biol Chem; 1985 Oct; 260(24):13003-7. PubMed ID: 4055730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a covalent linkage in the adriamycin-cardiolipin complex induced by adriamycin-mediated electron transport.
    Goormaghtigh E; Ruysschaert JM
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):149-52. PubMed ID: 6316434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the reversal by deoxyribonucleic acid of the binding of adriamycin to cardiolipin-containing liposomes.
    Mustonen P; Kinnunen PK
    J Biol Chem; 1993 Jan; 268(2):1074-80. PubMed ID: 7678246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin inhibits the phosphate-transport protein reconstituted in liposomes. A study on the mechanism of the inhibition.
    Müller M; Cheneval D; Carafoli E
    Eur J Biochem; 1984 May; 140(3):447-52. PubMed ID: 6723644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs.
    Nicolay K; Sautereau AM; Tocanne JF; Brasseur R; Huart P; Ruysschaert JM; de Kruijff B
    Biochim Biophys Acta; 1988 May; 940(2):197-208. PubMed ID: 3163502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary structure and orientation of a chemically synthesized mitochondrial signal sequence in phospholipid bilayers.
    Goormaghtigh E; Martin I; Vandenbranden M; Brasseur R; Ruysschaert JM
    Biochem Biophys Res Commun; 1989 Jan; 158(2):610-6. PubMed ID: 2537078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of adriamycin-Fe3+ complex to membrane phospholipids.
    Demant EJ
    Eur J Biochem; 1984 Aug; 142(3):571-5. PubMed ID: 6468379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of adriamycin with cardiolipin-containing vesicles. Evidence of an embedded site for the dihydroanthraquinone moiety.
    Fiallo MM; Garnier-Suillerot A
    Biochim Biophys Acta; 1986 Jan; 854(1):143-6. PubMed ID: 3002460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
    Henry-Toulme N; Stefanska B; Borowski E; Bolard J
    Mol Pharmacol; 1988 May; 33(5):574-9. PubMed ID: 3367905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
    Fiallo MM; Garnier-Suillerot A
    Biochemistry; 1986 Feb; 25(4):924-30. PubMed ID: 3964654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin and its iron(III) and copper(II) complexes. Glutathione-induced dissociation; cytochrome c oxidase inactivation and protection; binding to cardiolipin.
    Hasinoff BB; Davey JP
    Biochem Pharmacol; 1988 Oct; 37(19):3663-9. PubMed ID: 2845993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.